Exome sequencing of liver fluke-associated cholangiocarcinoma

Nat Genet. 2012 May 6;44(6):690-3. doi: 10.1038/ng.2273.

Abstract

Opisthorchis viverrini-related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major public health concern in areas endemic for this parasite. We report here whole-exome sequencing of eight O. viverrini-related tumors and matched normal tissue. We identified and validated 206 somatic mutations in 187 genes using Sanger sequencing and selected 15 genes for mutation prevalence screening in an additional 46 individuals with CCA (cases). In addition to the known cancer-related genes TP53 (mutated in 44.4% of cases), KRAS (16.7%) and SMAD4 (16.7%), we identified somatic mutations in 10 newly implicated genes in 14.8-3.7% of cases. These included inactivating mutations in MLL3 (in 14.8% of cases), ROBO2 (9.3%), RNF43 (9.3%) and PEG3 (5.6%), and activating mutations in the GNAS oncogene (9.3%). These genes have functions that can be broadly grouped into three biological classes: (i) deactivation of histone modifiers, (ii) activation of G protein signaling and (iii) loss of genome stability. This study provides insight into the mutational landscape contributing to O. viverrini-related CCA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bile Duct Neoplasms / genetics*
  • Bile Duct Neoplasms / parasitology*
  • Cholangiocarcinoma / genetics*
  • Cholangiocarcinoma / parasitology*
  • DNA-Binding Proteins / genetics
  • Exome
  • Fascioliasis / complications*
  • Female
  • Humans
  • Loss of Heterozygosity
  • Male
  • Middle Aged
  • Mutation
  • Receptors, Immunologic / genetics
  • Sequence Analysis, DNA

Substances

  • DNA-Binding Proteins
  • KMT2C protein, human
  • ROBO2 protein, human
  • Receptors, Immunologic